Waardenburg syndrome type 4A

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Waardenburg syndrome type 4A | |
|---|---|
| |
| Synonyms | Waardenburg-Shah syndrome |
| Pronounce | |
| Specialty | Medical genetics |
| Symptoms | Hearing loss, pigmentation abnormalities, Hirschsprung's disease |
| Complications | N/A |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation in the EDNRB, EDN3, or SOX10 genes |
| Risks | Family history of the condition |
| Diagnosis | Genetic testing, clinical evaluation |
| Differential diagnosis | Other types of Waardenburg syndrome, Hirschsprung's disease |
| Prevention | Genetic counseling |
| Treatment | Management of symptoms, cochlear implants for hearing loss, surgery for Hirschsprung's disease |
| Medication | N/A |
| Prognosis | Variable, depending on severity of symptoms |
| Frequency | Rare |
| Deaths | N/A |

Waardenburg Syndrome Type 4A (WS4A), also known as Waardenburg-Shah Syndrome, is a genetic disorder characterized by a combination of hearing loss, changes in skin pigmentation, and intestinal issues due to a condition known as Hirschsprung's disease. This syndrome represents one of the subtypes of Waardenburg Syndrome, which is a group of genetic conditions that can affect the color of a person's skin, hair, and eyes, and can cause hearing loss. WS4A is particularly distinguished by the presence of Hirschsprung's disease, which affects the large intestine and can cause severe constipation or intestinal obstruction.
Causes[edit]
WS4A is caused by mutations in the EDNRB gene, the EDN3 gene, or, less commonly, the SOX10 gene. These genes are involved in the development and function of neural crest cells, which are crucial for the development of various tissues and organs, including the melanocytes (cells that produce pigment in the skin and hair), the inner ear, and the enteric nervous system of the intestine.
Symptoms[edit]
The hallmark symptoms of Waardenburg Syndrome Type 4A include:
- Congenital deafness or significant hearing loss
- Patches of white skin or hair (due to lack of melanocytes)
- Bright blue eyes or one blue and one brown eye
- Distinctive facial features, such as a wide bridge of the nose
- Gastrointestinal issues due to Hirschsprung's disease, which can range from chronic constipation to life-threatening intestinal obstruction
Diagnosis[edit]
Diagnosis of WS4A typically involves a combination of physical examination, review of family history, and genetic testing to identify mutations in the EDNRB, EDN3, or SOX10 genes. Audiological, ophthalmological, and skin examinations may also be conducted to assess the extent of hearing, vision, and pigmentary disturbances. In cases where Hirschsprung's disease is suspected, a biopsy of the intestine may be performed to confirm the diagnosis.
Treatment[edit]
Treatment for Waardenburg Syndrome Type 4A is multidisciplinary and focuses on managing the symptoms of the condition. This may include:
- Hearing aids or cochlear implants for hearing loss
- Regular monitoring and treatment for skin and eye pigmentary changes
- Surgical intervention for Hirschsprung's disease, typically involving the removal of the affected portion of the intestine
- Genetic counseling for affected individuals and their families
Prognosis[edit]
The prognosis for individuals with Waardenburg Syndrome Type 4A varies depending on the severity of the symptoms and the success of treatment interventions, particularly for Hirschsprung's disease. With appropriate management, most individuals with WS4A can lead normal, healthy lives.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
